Logotype for Arctic Bioscience

Arctic Bioscience (ABS) investor relations material

Arctic Bioscience Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Arctic Bioscience
Q3 2025 earnings summary10 Nov, 2025

Executive summary

  • Statistically significant anti-inflammatory effects of HRO350 were demonstrated in the HeROPA/Europa studies, with improved skin symptoms and quality of life in psoriasis and confirmation of benefits in the per-protocol population.

  • Clinical glaucoma studies confirmed neuroprotective potential and vision improvement with ROMEGAⓇ herring caviar oil, with plans for larger trials and ongoing partner discussions.

  • Strong Nutra sales rebound in the Americas, with new customers and leads driving growth, and further expansion expected through 2026.

  • Operational focus on cost reduction, with OPEX down by NOK 8.9 million year-over-year and minimal CAPEX in pharma following study completions.

  • NOK 2.5 million grant awarded for oral aquaculture vaccine development, and Arctic Orphan (ABS302) project reached a key product formulation milestone.

Financial highlights

  • Q3 2025 sales revenues were NOK 8.7 million, down from NOK 11.1 million in Q3 2024, with Nutra revenues slightly down year-over-year due to recall impacts.

  • Gross margin for Q3 2025 was 21.6%, down from 31.8%/33.5% in Q3 2024, impacted by recall-related costs and a NOK 2.3 million provision in 2024.

  • EBITDA for YTD Q3 2025 was NOK -21.4 million, improved from NOK -31.0 million in 2024.

  • Available liquidity at quarter-end was NOK 7.0–7.5 million, with ongoing focus on cost control and income growth.

  • American market revenue grew by over NOK 6 million year-over-year, surpassing 2024's total.

Outlook and guidance

  • Anticipates strong year-end and further growth in Americas and B2B channels, with recurring business from new customers and B2C expansion in Northern Europe and Asia pending regulatory approvals.

  • Strategic partnerships and regulatory engagement for HeROPA/HRO350 development are being pursued, with further development to be funded through partnerships or project-specific funding.

  • Liquidity situation is closely monitored, with ongoing board assessment and positive bank dialogue.

  • Significant upside potential in cost supplement business expected in 2026.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Arctic Bioscience earnings date

Logotype for Arctic Bioscience
Q4 20251 Apr, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Arctic Bioscience earnings date

Logotype for Arctic Bioscience
Q4 20251 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Arctic Bioscience ASA is a biotechnology company specializing in the development and production of health products derived from marine ingredients, particularly omega-3 fatty acids from herring roe. The company's products are used in the nutraceutical and pharmaceutical sectors, offering health benefits related to brain, heart, and immune function. In addition to producing omega-3-based supplements for consumer markets, Arctic Bioscience is involved in the research and development of new pharmaceutical applications utilizing marine-based bioactive compounds. The company is headquartered in Ørsta, Norway, and its shares are listed on the Oslo Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage